Uterine leiomyoma: Available medical treatments and new possible therapeutic options

Keyphrases

• Therapeutic Potential 100%
• Uterine Leiomyoma 100%
• Medical Treatment 100%
• Leiomyoma 100%
• Abnormal Uterine Bleeding 100%
• Medical Therapy 66%
• Fibroids 66%
• Intrauterine Device 66%
• Tumor 33%
• Benign Tumor 33%
• Chemokines 33%
• Symptomatic Improvement 33%
• Growth Factors 33%
• Pathophysiology 33%
• Genetic Factors 33%
• Clinical Trials 33%
• PubMed 33%
• Estrogen 33%
• Progesterone 33%
• U.S. Food 33%
• Gonadotropin-releasing Hormone 33%
• Infertility 33%
• Uterus 33%
• Recurrent Pregnancy Loss 33%
• Women of Reproductive Age 33%
• Epigenetic Factors 33%
• Pathogenetic Factors 33%
• Natural Compounds 33%
• Synthetic Compounds 33%
• Laboratory Investigation 33%
• Pelvic Pain 33%
• Evidence Acquisition 33%
• Future Therapeutics 33%
• Extracellular Matrix Protein 1 (ECM1) 33%
• Google Scholar 33%
• Myoma 33%
• Factor Matrix 33%
• Pelvic Pressure 33%
• Epigallocatechin Gallate 33%
• Fibroid Size 33%
• Levonorgestrel-releasing Intrauterine System (LNG-IUS) 33%
• Mifepristone 33%
• Factor Inhibitors 33%
• Ulipristal Acetate 33%
• Mirena 33%
• Asoprisnil 33%

Medicine and Dentistry

• Uterine Fibroid 100%
• Combination Therapy 100%
• Angioleiomyoma 75%
• Intrauterine Device 50%
• Levonorgestrel 50%
• Neoplasm 25%
• Benign Tumor 25%
• Symptom 25%
• Cytokine 25%
• Growth Factor 25%
• Pathophysiology 25%
• Extracellular Matrix 25%
• Heredity 25%
• Clinical Trial 25%
• Natural Product 25%
• Chemokine 25%
• Myoma 25%
• Recurrent Pregnancy Loss 25%
• Progesterone 25%
• Pelvic Pain 25%
• Growth, Development and Aging 25%
• Uterus Bleeding 25%
• Gonadotropin-Releasing Hormone 25%
• Mifepristone 25%
• Menorrhagia 25%
• Ulipristal 25%
• Epigallocatechin Gallate 25%
• Asoprisnil 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Uterus Myoma 100%
• Leiomyoma 75%
• Intrauterine Device 50%
• Levonorgestrel 50%
• Neoplasm 25%
• Clinical Trial 25%
• Symptom 25%
• Chemokine 25%
• Cytokine 25%
• Pathophysiology 25%
• Natural Product 25%
• Growth Factor 25%
• Progesterone 25%
• Benign Neoplasm 25%
• Mifepristone 25%
• Epigallocatechin Gallate 25%
• Menorrhagia 25%
• Uterus Bleeding 25%
• Myoma 25%
• Pelvic Pain 25%
• Ulipristal 25%
• Asoprisnil 25%